Edgar Filing: DE SILVA RAJIV

Ownership Submission

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0104

Expires:

January 31, 2005

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

Â DE SILVA RAJIV

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2013

3. Issuer Name and Ticker or Trading Symbol
ENDO HEALTH SOLUTIONS INC. [ENDP]

(Last)

(First)

(Middle)

C/O ENDO HEALTH SOLUTIONS INC.,Â 1400 ATWATER DRIVE

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

__X__ Director	_____ 10% Owner
__X__ Officer (give title below)	_____ Other (specify below)
President & CEO

5. If Amendment, Date Original Filed(Month/Day/Year)

(Street)

MALVERN,Â PAÂ 19355

6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock, par value, $0.01 per share ⁽¹⁾	158,403	D	Â
Common Stock, par value, $0.01 per share ⁽¹⁾	63,315	I	Held in trusts
2010 Stock Incentive Plan Restricted Stock Units (RSU) ⁽²⁾ ⁽³⁾	41,091 ⁽⁴⁾	D	Â
2010 Stock Incentive Plan Performance Shares ⁽⁵⁾	82,182 ⁽⁴⁾ ⁽⁶⁾	D	Â
2010 Stock Incentive Plan Matched Performance Shares ⁽⁷⁾	82,182 ⁽⁸⁾ ⁽⁹⁾	D	Â

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
2010 Stock Incentive Plan Stock Options ⁽¹⁰⁾	Â ⁽¹¹⁾	03/18/2023	Common Stock	135,899 ⁽⁴⁾	$ 30.42	D	Â

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
DE SILVA RAJIV C/O ENDO HEALTH SOLUTIONS INC. 1400 ATWATER DRIVE MALVERN,Â PAÂ 19355	Â X	Â	Â President & CEO	Â

Signatures

/s/ Caroline B. Manogue, by power of attorney		03/20/2013
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	As part of Mr. De Silva's personal financial planning, he purchased these shares on the open market on March 6, 2013, prior to becoming a reporting person. Pursuant to Mr. De Silva's employment agreement, Mr. De Silva is required to retain ownership of at least $5,000,000, representing aggregate purchase price, of purchased common stock until at least March 18, 2016 (or earlier upon certain circumstances as defined in Mr. De Silva's Employment Agreement).
(2)	Upon each vesting date, each vested restricted stock unit automatically converts into one (1) share of common stock of Endo Health Solutions Inc.
(3)	These restricted stock units (RSUs) generally vest 33-1/3% on each of December 31, 2013, December 31, 2014 and March 18, 2016. Upon vesting, we consider the underlying RSUs to be expired.
(4)	These securities were granted to Mr. De Silva in connection with his commencement of employment in consideration of his anticipated services as the President & Chief Executive Officer of Endo Health Solutions Inc.
(5)	These performance shares vest on December 31, 2015 upon the Company achieving certain shareholder return targets over the period beginning on January 1, 2013 and ending on December 31, 2015.
(6)	Represents target quantity of shares issuable. The exact number of shares issuable will be determined on achievement of certain shareholder return targets over a cumulative 3-year period, as determined by the Board of Directors of Endo Health Solutions Inc. Mr. De Silva can earn between 0% and 300% of the target shares.
(7)	The matched performance shares vest on March 18, 2016 upon the Company achieving certain shareholder return targets over the period beginning on March 18, 2013 and ending on March 18, 2016 (or earlier upon certain circumstances as defined in Mr. De Silva's Employment Agreement).
(8)	Pursuant to Mr. De Silva's employment agreement, the Registrant matched up to $2,500,000 of Mr. De Silva's open market purchases of common stock, which occurred on March 6, 2013 as reported above. These matched performance shares were granted to Mr. De Silva on March 18, 2013 in consideration of his anticipated services as the President & Chief Executive Officer of Endo Health Solutions Inc.
(9)	Represents target quantity of shares issuable. The exact number of shares issuable will be determined on achievement of certain shareholder return targets over a cumulative 3-year period, as determined by the Board of Directors of Endo Health Solutions Inc. Mr. De Silva can earn between 0% and 150% of the target shares. Pursuant to Mr. De Silva's employment agreement, Mr. De Silva is required to retain ownership of the shares issued in respect of these matched performance shares for a period of two years from the date of delivery of such shares.
(10)	Represents the right to buy shares of common stock, par value $0.01 per share, of Endo Health Solutions Inc.
(11)	These stock options are generally exercisable 33-1/3% per year on each of December 31, 2013, December 31, 2014 and December 31, 2015.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.